Stockscreener 앱 받기
1.63
1.24%
0.02
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions completes fingerprint drug screening system study - Yahoo! Voices
Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks
Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times
Intelligent Bio Solutions Inc. Achieves 94.1% Accuracy in Method Comparison Study, Following Positive Pk Study Results - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan
Intelligent Bio Solutions raises $250k via stock sales - Investing.com
INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com
Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com UK
INBS (Intelligent Bio Solutions) Inventory Turnover : 0.69 (As of Sep. 2024) - GuruFocus.com
Intelligent Bio Solutions Announces Study Results and Stock Sale - TipRanks
INBS (Intelligent Bio Solutions) Price-to-Free-Cash-Flow : N/A (As of Nov. 20, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Intelligent Bio : INBS PK Study Results Video - Marketscreener.com
INBS (Intelligent Bio Solutions) EBITDA per Share : $-30.36 (TTM As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Total Assets : $11.73 Mil (As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) PensionAndRetirementBenefi - GuruFocus.com
INBS (Intelligent Bio Solutions) Price-to-Operating-Cash-Fl - GuruFocus.com
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - MSN
Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com
Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance
INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia
Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
INBS advances in drug detection with fingerprint technology - Investing.com
Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - GlobeNewswire
Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. (INBS) Quarterly 10-Q Report - Quartzy
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - The Manila Times
ConnectM to Participate in the 13th Annual Roth Technology Conference - The Manila Times
Intelligent Bio Solutions Revenue Surges 20% QoQ, FDA Study Milestone Achieved | INBS Stock News - StockTitan
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach - Yahoo Finance
Intelligent Bio Solutions Inc (INBS-Q) QuotePress Release - The Globe and Mail
Intelligent Bio Solutions partners with B2i Digital for marketing push - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.58% - MSN
Intelligent Bio Solutions Partners with B2i Digital to Enhance Investor Engagement - EIN News
Intelligent Bio Solutions partners with B2i Digital for marketing push By Investing.com - Investing.com UK
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - The Manila Times
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - The Manila Times
Intelligent Bio Solutions reports revenue growth and strategic expansion By Investing.com - Investing.com South Africa
Intelligent Bio Solutions reports revenue growth and strategic expansion - Investing.com
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - The Manila Times
TeraWulf Schedules Conference Call for Third Quarter 2024 Financial Results - The Manila Times
Intelligent Bio Solutions Inc. Provides Revenue Guidance for the First Quarter Ended September 30, 2024 - Marketscreener.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.65% - MSN
ConnectM Launches Intelligent AI-Driven Heat Pump Following AHRI Cold Climate Certification - The Manila Times
Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil - The Manila Times
Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Mitchell Advocate
0.65%
자본화:
|
볼륨(24시간):